Lead Change Blog
JULY 6, 2015
Making money is inspiring for your owners and stakeholders but it has little tactical relevance to front line employees. The second example, from a pharmaceutical company, states their purpose is “to discover, develop, and deliver innovative medicines that help patients prevail over serious diseases.”
Harvard Business Review
MAY 8, 2013
I recently conducted a study of 56 randomly selected companies involved in major change and innovation efforts in the high-tech, retail, pharmaceutical, banking, automotive, insurance, energy, non-profit, and health care industries. Nearly 68% of these large-scale change and innovative efforts failed.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Harvard Business Review
JUNE 20, 2017
For organizations seeking to become more adaptive and innovative, culture change is often the most challenging part of the transformation. Innovation demands new behaviors from leaders and employees that are often antithetical to corporate cultures, which are historically focused on operational excellence and efficiency.
Harvard Business Review
APRIL 22, 2013
Most of us think of biotech as the province of multinational pharmaceutical corporations and well-funded ventures, but the founders of BioCurious believe (as they say in their mission statement) "that innovations in biology should be accessible, affordable, and open to everyone." But don''t let that loss of control frighten you.
Harvard Business Review
DECEMBER 23, 2016
What distinguished successful from unsuccessful alliances was more of a “productive” irritation — creative tension between differing ideas about how to develop alliance products – reflected in disagreements about the strategy and tactics of how best to develop a particular molecule.
Strategy Driven
JANUARY 24, 2011
Closing the Execution Gap : How Great Leaders and Their Companies Get Results by Richard Lepsinger If an organization can’t execute its plans and initiatives, nothing else matters: not the most solid, well thought-out strategy, not the most innovative business model, not even technological breakthroughs that could transform an industry.
Harvard Business Review
NOVEMBER 2, 2018
Workers’ increasing out-of-pocket costs are creating widespread discontent with the underlying costs of care — a problem largely driven by the high prices charged to private payers for health services and pharmaceuticals. Data from the Commonwealth Fund’s biennial survey of the American public shows that the percent of U.S.
Expert insights. Personalized for you.
150 
Let's personalize your content